[1] 何坤,胡泽民,阮嘉后,等.肝癌合并胆管癌栓的外科手术治疗疗效分析[J].肝胆外科杂志,2017,25(4):269-272. [2] 马达,丁佑铭.肝细胞癌合并胆管癌的临床分型及手术方式对其远期疗效的影响[J].实用癌症杂志,2017,32(1):121-123. [3] Arunraj TR, Sanoj Rejinold N, Ashwin Kumar N,et al.Bio-responsive chitin-poly(L-lactic acid) composite nanogels for liver cancer[J].Colloids Surf B Biointerfaces,2014,113:394-402. [4] Pollicino T, Musolino C, Saitta C,et al.Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma[J].Oncotarget,2019,10(39):3931-3938. [5] 殷晓煜,刘鑫,陈伟,等.肝门部胆管癌手术切除的远期疗效及预后因素分析[J].中华消化外科杂志,2016,15(4):329-334. [6] 戴海粟.联合肝动脉切除重建在肝门部胆管癌根治术中的临床研究[J].中华外科杂志,2018,56(1):41-46. [7] Sugiura K, Mishima T, Takano S,et al.The Expression of Yes-Associated Protein (YAP) Maintains Putative Cancer Stemness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma[J].Am J Pathol,2019 ,13(34):2143-2149. [8] Tian X, Ma P, Sui C,et al.Comprehensive assessment of the association between tumor necrosis factor alpha G238A polymorphism and liver cancer risk[J].Tumour Biol,2014,35(1):103-109. [9] 张辉,王孟龙.单中心56例肝门部胆管癌的外科治疗[J].中华肝胆外科杂志,2017,23(1):16-19. [10] Li YR, Wang JR, Zhang, HY,et al.Dynamic morphological examination and evaluation of biological characteristics of a multinodular liver cancer model in mice[J].Lab Anim,2014,48(2):132-142.
2019, Vol. 36 
